Interscience Conference on Antimicrobial Agents and Chemotherapy - 50th Annual Meeting - Research on Promising New Agents: Part 2.
The 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Boston, included topics covering new therapeutic developments in the field of infectious disease. This conference report highlights selected presentations on research with novel antimicrobial agents. Investigational drugs discussed include the chitin synthase inhibitor nikkomycin Z (Valley Fever Solutions/University of Arizona), the glycosylphosphatidylinositol biosynthesis inhibitor E-1210 (Eisai), the β-1,3-d-glucan synthesis inhibitor MK-3118 (Merck & Co/SCYNEXIS), the metalloenzyme inhibitors VT-1129 and VT-1161 (both Viamet Pharmaceuticals), and the anti-inflammatory nanoemulsion NB-003 (NanoBio).
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. karen.walker@thomsonreuters.com
Karen
K
Walker
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D003141:Communicable Diseases / Q000188:drug therapy* / Q000382:microbiology; D015195:Drug Design; D015507:Drugs, Investigational / Q000494:pharmacology; D006801:Humans; D011725:Pyridines / Q000494:pharmacology*; D013777:Tetrazoles / Q000494:pharmacology*
D000890:Anti-Infective Agents; D015507:Drugs, Investigational; D011725:Pyridines; D013777:Tetrazoles; C000599187:VT-1161